These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18499932)

  • 21. Delirium with visual hallucinations induced by low-dose olanzapine.
    Takeuchi N; Makino T; Nishihara M
    Psychogeriatrics; 2022 May; 22(3):415-416. PubMed ID: 35274396
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 23. Quetiapine treatment in early psychosis: no evidence of cataracts.
    Whitehorn D; Gallant J; Woodley H; Rui Q; Milliken H; Kopala L
    Schizophr Res; 2004 Dec; 71(2-3):511-2. PubMed ID: 15474924
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
    Citrome L; Krakowski M; Greenberg WM; Andrade E; Volavka J
    J Clin Psychiatry; 2001 Nov; 62(11):901. PubMed ID: 11775051
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological management of anxiety in patients suffering from schizophrenia].
    Baylé FJ; Blanc O; De Chazeron I; Lesturgeon J; Lançon C; Caci H; Garay RP; Llorca PM
    Encephale; 2011 May; 37 Suppl 1():S83-9. PubMed ID: 21600338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic delirium with low-dose clozapine.
    Wilkins-Ho M; Hollander Y
    Can J Psychiatry; 1997 May; 42(4):429-30. PubMed ID: 9161772
    [No Abstract]   [Full Text] [Related]  

  • 27. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outpatient use of atypical antipsychotics with Alzheimer's disease.
    Farver D
    S D Med; 2007 Mar; 60(3):113, 115. PubMed ID: 17455580
    [No Abstract]   [Full Text] [Related]  

  • 29. Skin rash occurring with olanzapine pamoate, but not with oral olanzapine, in a male with juvenile idiopathic arthritis.
    Solfanelli A; Curto M; Dimitri-Valente G; Kotzalidis GD; Gasperoni C; Sani G; Manfredi G; Rapinesi C; Comparelli A; Girardi P
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):232-4. PubMed ID: 23607414
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndrome.
    Skomedal T; Hanem S; Dybvik T; Ilner SO
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2238-9. PubMed ID: 24226327
    [No Abstract]   [Full Text] [Related]  

  • 31. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical limitations of prescribing olanzapine depot (Relprevv).
    Devadason P
    Australas Psychiatry; 2010 Jun; 18(3):269. PubMed ID: 20482436
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of akathisia after switching from branded to generic high-dose olanzapine.
    Goldberg JF
    J Clin Psychiatry; 2012 Apr; 73(4):497. PubMed ID: 22579148
    [No Abstract]   [Full Text] [Related]  

  • 36. [Post-injection syndrome and olanzapine pamoate: A severe case report].
    Descusse A; Chebili S; Artiges E
    Encephale; 2017 Aug; 43(4):405. PubMed ID: 27349579
    [No Abstract]   [Full Text] [Related]  

  • 37. Delirium with anticholinergic symptoms after a combination of paliperidone and olanzapine pamoate in a patient known to smoke cannabis: an unfortunate coincidence.
    Kokalj A; Rijavec N; Tavčar R
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged delirium after quetiapine overdose.
    Rhyee SH; Pedapati EV; Thompson J
    Pediatr Emerg Care; 2010 Oct; 26(10):754-6. PubMed ID: 20930599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine may cause delirium in geriatric patients.
    Samuels S; Fang M
    J Clin Psychiatry; 2004 Apr; 65(4):582-3. PubMed ID: 15119927
    [No Abstract]   [Full Text] [Related]  

  • 40. Addictive potential of quetiapine.
    Murphy D; Bailey K; Stone M; Wirshing WC
    Am J Psychiatry; 2008 Jul; 165(7):918. PubMed ID: 18593794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.